Peptide

Cagrilintide

Also called cagri, cagrisema

A long-acting amylin analogue for weight loss, tested with semaglutide as CagriSema.

Track this in StackbaseFree. Your doses, streaks and supplies in one private place.

What it is

Cagrilintide copies amylin, a hormone released together with insulin that makes you feel full. It lasts about a week. On its own it led to around 10% weight loss in a phase 2 trial; combined with semaglutide (CagriSema) the results were larger. It is not approved yet.

How it’s used

  • Injected under the skin once a week, often alongside semaglutide, with slow dose increases.

Typical amounts

  • Trials used 0.16 to 4.5 mg a week. CagriSema pairs 2.4 mg of cagrilintide with 2.4 mg of semaglutide.

Good to know

  • Not approved; products sold now are unregulated.
  • Nausea, constipation and tiredness are common at the start.

Educational information, not medical advice. Check anything you take with a doctor or pharmacist.